Key result
Advanced CMR techniques enable comprehensive evaluation of myocardial microstructure in non-ischemic cardiomyopathies.
Why the study?
Traditional CMR late gadolinium enhancement cannot effectively identify diffuse myocardial fibrosis, prompting the need to discuss research advances, clinical prospects, and limitations of newer CMR techniques in non-ischemic cardiomyopathies.
Advanced CMR techniques such as T1 mapping, diffusion tensor imaging, and feature tracking offer promising clinical applications for evaluating myocardial microstructure and early dysfunction in non-ischemic cardiomyopathies.
Answers are grounded in this paper and cite their sources.
Facilitates microstructural phenotyping in non-ischemic cardiomyopathy; leaves open prospective outcome validation before clinical adoption.
Cardiac magnetic resonance (CMR), a non-radiation based type of examination, can achieve the simultaneous comprehensive multi-parameter, multi-plane, and multi-sequence evaluation of the anatomical structure of the heart; and at the same time, determine systolic and diastolic function, and blood perfusion and tissue characteristics. Traditional late gadolinium enhancement imaging based on CMR reflects focal replacement fibrosis, in contrast to normal myocardial signal intensity, but cannot effectively identify diffuse myocardial fibrosis. T1 mapping and its derived extracellular volume fraction can be used to quantitatively analyze the extracellular space in myocardial tissue and evaluate diffuse myocardial interstitial fibrosis that is invisible to the naked eye. Diffusion tensor imaging reveals the direction of cardiomyocyte aggregates by quantifying the anisotropy of water molecule diffusion, and can be applied to evaluate the integrity of myocardial tissue and arrangement structure of myocardial microstructural characteristics. On the basis of the micro-motion of myocardial tissue, feature tracking analysis decomposes myocardial deformation into three dimensions of micro-mechanical changes, and can identify early systolic and diastolic dysfunction before heart enlargement or ejection fraction reduction. This Commentary discusses current research advances in these new techniques, as well as their clinical application prospects and limitations for non-ischemic cardiomyopathies.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2024) conducted a review in Non-ischemic cardiomyopathies. Advanced Cardiac Magnetic Resonance techniques (T1 mapping, diffusion tensor imaging, feature tracking) was evaluated. Advanced cardiac magnetic resonance techniques, including T1 mapping and diffusion tensor imaging, enable comprehensive evaluation of myocardial microstructure in non-ischemic cardiomyopathies.
Synapse has enriched 10 related papers. Consider them for comparative context: